Microbiological Research Authority – Trademark Portfolio

Entity Type: 15

Microbiological Research Authority holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. The owner is based in Salisbury, Wiltshire SP4 0JG.

Centre for Applied Microbiology &

Research Porton Down

Salisbury, Wiltshire SP4 0JG , GB

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ERWINASE
ERWINASE
Cancelled 2002
CAMR
CAMR
Cancelled 2001

Trademark Classifications

Microbiological Research Authority's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Microbiological Research Authority have?

Microbiological Research Authority has 3 U.S. trademarks filed with the USPTO.

What trademark classes does Microbiological Research Authority file in?

Microbiological Research Authority files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Microbiological Research Authority's trademark registration success rate?

Microbiological Research Authority has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.